Swayne DE - Search Results

1

Cross-clade immunity in cats vaccinated with a canarypox-vectored avian influenza vaccine.

Stittelaar KJ, Lacombe V, van Lavieren R, van Amerongen G, Simon J, Cozette V, Swayne DE, Poulet H, Osterhaus AD. Stittelaar KJ, et al. Among authors: swayne de. Vaccine. 2010 Jul 12;28(31):4970-6. doi: 10.1016/j.vaccine.2010.05.028. Epub 2010 May 28. Vaccine. 2010. PMID: 20566392

2

Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert.

Swayne DE, Garcia M, Beck JR, Kinney N, Suarez DL. Swayne DE, et al. Vaccine. 2000 Jan 6;18(11-12):1088-95. doi: 10.1016/s0264-410x(99)00369-2. Vaccine. 2000. PMID: 10590330

3

Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate.

Chen H, Subbarao K, Swayne D, Chen Q, Lu X, Katz J, Cox N, Matsuoka Y. Chen H, et al. Vaccine. 2003 May 16;21(17-18):1974-9. doi: 10.1016/s0264-410x(02)00809-5. Vaccine. 2003. PMID: 12706686

4

Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate.

Chen H, Matsuoka Y, Swayne D, Chen Q, Cox NJ, Murphy BR, Subbarao K. Chen H, et al. Vaccine. 2003 Oct 1;21(27-30):4430-6. doi: 10.1016/s0264-410x(03)00430-4. Vaccine. 2003. PMID: 14505926

5

Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.

Desheva JA, Lu XH, Rekstin AR, Rudenko LG, Swayne DE, Cox NJ, Katz JM, Klimov AI. Desheva JA, et al. Among authors: swayne de. Vaccine. 2006 Nov 17;24(47-48):6859-66. doi: 10.1016/j.vaccine.2006.06.023. Epub 2006 Jun 28. Vaccine. 2006. PMID: 17050041

6

Development and evaluation of an Influenza virus subtype H7N2 vaccine candidate for pandemic preparedness.

Pappas C, Matsuoka Y, Swayne DE, Donis RO. Pappas C, et al. Among authors: swayne de. Clin Vaccine Immunol. 2007 Nov;14(11):1425-32. doi: 10.1128/CVI.00174-07. Epub 2007 Oct 3. Clin Vaccine Immunol. 2007. PMID: 17913860 Free PMC article.

7

A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus.

Steel J, Burmakina SV, Thomas C, Spackman E, García-Sastre A, Swayne DE, Palese P. Steel J, et al. Among authors: swayne de. Vaccine. 2008 Jan 24;26(4):522-31. doi: 10.1016/j.vaccine.2007.11.032. Epub 2007 Dec 3. Vaccine. 2008. PMID: 18093698 Free PMC article.

8

Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.

Jadhao SJ, Achenbach J, Swayne DE, Donis R, Cox N, Matsuoka Y. Jadhao SJ, et al. Among authors: swayne de. Vaccine. 2008 Mar 25;26(14):1742-50. doi: 10.1016/j.vaccine.2008.01.036. Epub 2008 Feb 13. Vaccine. 2008. PMID: 18336962

9

Characterization and efficacy determination of commercially available Central American H5N2 avian influenza vaccines for poultry.

Eggert D, Thomas C, Spackman E, Pritchard N, Rojo F, Bublot M, Swayne DE. Eggert D, et al. Among authors: swayne de. Vaccine. 2010 Jun 23;28(29):4609-15. doi: 10.1016/j.vaccine.2010.04.081. Epub 2010 May 12. Vaccine. 2010. PMID: 20470798

10

H7 avian influenza virus vaccines protect chickens against challenge with antigenically diverse isolates.

Abbas MA, Spackman E, Fouchier R, Smith D, Ahmed Z, Siddique N, Sarmento L, Naeem K, McKinley ET, Hameed A, Rehmani S, Swayne DE. Abbas MA, et al. Among authors: swayne de. Vaccine. 2011 Oct 6;29(43):7424-9. doi: 10.1016/j.vaccine.2011.07.064. Epub 2011 Jul 29. Vaccine. 2011. PMID: 21803098

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

360 results

Search Page

Filters